Phathom Pharmaceuticals
PHAT
PHAT
61 hedge funds and large institutions have $719M invested in Phathom Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
0.36% less ownership
Funds ownership: 75.77% → 75.41% (-0.36%)
Holders
61
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$16.2M | |
| 2 | +$8.31M | |
| 3 | +$5.84M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$5.15M |
| 5 |
BlackRock
New York
|
+$4.64M |
Top Sellers
| 1 | -$47.9M | |
| 2 | -$11.7M | |
| 3 | -$2.93M | |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$485K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$368K |